Rejected at 2:21 p.m. Jan, 17, 2026 ] by braviboron
Author: gski
Related Note: 1674903334002
Rationale for change

clopidogrel is second line, ticagrelor or prasugrel is first line P2Y12 inhibitor

Rejection reason

This suggestion is stale, but the edits have been manually incorporated.

Text Text
Extra
Extra (Synced)
Empty field
Personal Notes
Empty field
Missed Questions
Empty field
eTG Complete
Empty field
Talley & O'Connor
Empty field
Additional Resources
Empty field
Additional Resources (Synced)
Empty field
Source
One by one
#Malleus_CM::#Question_Banks::eMedici::1000-1999::1422 #Malleus_CM::#Subjects::Cardiology::01_Coronary_&_Ischaemic_Heart_Disease::STEMI::10_Management #Malleus_CM::#Subjects::Critical_Care::03_Circulation::01_Acute_Coronary_Syndrome::STEMI::10_Management #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology #Malleus_CM::#Yield::High #Malleus_CM::#Question_Banks::eMedici::4000-4999::4131 #Malleus_CM::#Resources_by_Rotation::Emergency